Literature DB >> 6796292

Lipid and apolipoprotein levels in patients with nephrotic syndrome.

T Ohta, I Matsuda.   

Abstract

Plasma lipids and 6 plasma apolipoproteins (apoA-I, apoA-II, apoB, apoC-I, apoC-II and apoC-III) were studied in 23 patients with nephrotic syndrome. The elevated total cholesterol, triglyceride and apoB levels in nephrotic patients decreased gradually, after the disappearance of proteinuria. During the acute stage high density lipoprotein cholesterol, as well as the sum of apoA-I and apoA-II were similar in the patients and the controls. ApoA-I and apoA-II were transiently elevated during the recovery stage. All three apoC proteins (apoC-I, apoC-II and apoC-III) were elevated during the acute stage. A significant decrease in apoC-I, apoC-II and apoC-III was observed during the first 3 weeks after normalization of the urine protein. The ratio of apoC-II/apoC-III was reduced during the first 4 weeks after normalization of urine protein and then returned to the control level. The results suggest that as far as total levels are concerned, changes of apoC-II, apoC-III and the ratio of apoC-II/apoC-III appear to have no effect on the development of hyperlipidemia in th nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796292     DOI: 10.1016/0009-8981(81)90034-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

Review 2.  Management of nephrotic syndrome in childhood.

Authors:  T Melvin; W Bennett
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

3.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

Review 4.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

5.  Follow up study on children with dyslipidaemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment.

Authors:  T Ohta; R Nakamura; Y Ikeda; S Hattori; I Matsuda
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

Review 6.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

8.  The lipid story in chronic kidney disease: a long story with a happy end?

Authors:  Agata Kujawa-Szewieczek; Andrzej Więcek; Grzegorz Piecha
Journal:  Int Urol Nephrol       Date:  2013-10       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.